Talk:STAR*D

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Low	This article has been rated as Low-importance on the project's importance scale.

Chronology timeline

I think this entry article on the STAR*D desperately needs to reference the study timeline, or at least some solid clinical trial dates, to put it into current context. Clinicaltrials.gov suggests that Principal investigator A. John Rush launched STAR*D in July 2001, but material on edc.gsph.pitt.edu/stard/ indicates the actual groundwork for this NIMH-funded study started before October 1999. Might be a good idea to cite which regional centers the participant population was finally drawn from, too. -Theicla (talk) 08:59, 11 April 2015 (UTC)[reply]

Novel Finding:

A major surprise of the study was that Buspar is actually effective. The study was also notable for popularizing antidepressant augmentation, such as their adding Buspirone to an existing SSRI treatment. ^[1]

^ "An Update on the Treatment of Treatment Resistant Depression".

[1] "An Update on the Treatment of Treatment Resistant Depression".

[1]